US data shows AstraZeneca vaccine effective against COVID-19 for all adults

LONDON — Long-awaited preliminary data from final-stage testing in the United States of a COVID-19 vaccine developed by England’s University of Oxford and British-Swedish pharmaceutical giant AstraZeneca shows the two-dose shot is highly effective in all age and ethnicity groups, stopped hospitalization in all cases and did not raise the overall risk of blood clots. The Oxford/AstraZeneca vaccine was 79% […]
Continue reading »